KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Supernus Pharmaceuticals (SUPN) Short-Term Debt repayments (2023)

Historic Short-Term Debt repayments for Supernus Pharmaceuticals (SUPN) over the last 1 years, with Q2 2023 value amounting to $78.4 million.

  • Supernus Pharmaceuticals' Short-Term Debt repayments changed N/A to $78.4 million in Q2 2023 from the same period last year, while for Mar 2024 it was $78.4 million, marking a year-over-year increase of 43537.61%. This contributed to the annual value of $93.0 million for FY2023, which is N/A changed from last year.
  • As of Q2 2023, Supernus Pharmaceuticals' Short-Term Debt repayments stood at $78.4 million.
  • In the past 5 years, Supernus Pharmaceuticals' Short-Term Debt repayments ranged from a high of $78.4 million in Q2 2023 and a low of $14.6 million during Q1 2023